Essential details
Shipping:Express Delivery
Product Introduction
The Microbial Gateway to Endogenous GLP-1 & Metabolic Control
Beyond conventional GLP-1 agonists, Akkermansia muciniphilaAKK PROBIO offers a microbiome-driven metabolic approach. It secretes the P9 protein, which binds to ICAM-2 on intestinal L-cells, triggering endogenous GLP-1 secretion via cAMP/PKA pathways. Concurrently, it upregulates UCP-1 in brown adipose tissue, increasing energy expenditure. Clinical RCTs (130 subjects, 8 weeks) showed ~1.3kg weight reduction, 4.2cm waist circumference reduction, and improved insulin sensitivity—without exogenous peptides.
Core Mechanism: P9/Amuc_1100 → L-cell Activation → GLP-1↑ → Appetite/Satiety Regulation + UCP-1↑ → Thermogenesis → Adipose Reduction.
Core Advantages
1. Endogenous GLP-1 Induction
P9 protein directly stimulates gut L-cells to release native GLP-1 (Nature Microbiol 2021 supported).
2. Dual Fat Modulation
Reduces lipid accumulation (↓MDA, ↑SOD/GSH) + enhances browning of WAT via UCP-1.
3. Insulin Sensitivity
Pasteurized AKK shown to improve insulin sensitivity by ~30% (human pilot, Nature Med 2019 concept).
4. Clinical Weight Data
RCT: 8-week AKK PROBIO live form → -1.3kg body weight, -1.27kg fat mass, -4.2cm waist (Food Sci Hum Wellness 2025).
5. Gut-Metabolism Axis
Lowers systemic LPS (endotoxemia), improves NAFLD/atherosclerosis markers (Circulation 2016).
6. Safe Long-Term Use
No refractory vomiting/diarrhea typical of synthetic GLP-1 analogs; GRAS safety profile.
Weight Management & Metabolic Benefits
①Appetite & Satiety: Elevated endogenous GLP-1 slows gastric emptying, enhances satiety signaling.②Adipose Reduction: Decreases visceral fat; P9/UCP-1 pathway increases thermogenesis in BAT.
③Glycemic Control: Improves HOMA-IR, fasting insulin; supports T2DM adjunct management.
④Lipid & CVD: Attenuates atherosclerotic lesions (−31% lesion area in Apoe⁻/⁻ mice); lowers TC/TG.
⑤Inflammation & Gout: Reduces ankle edema & MPO/MDA in acute gouty arthritis models; anti-inflammatory cytokine shift (IL-10↑).
Recommended Applications
Weight Management: Meal replacement synbiotics, GLP-1 support capsules, appetite-control gummies.
Metabolic Formulas: Insulin-sensitivity blends, T2DM adjunct nutraceuticals.
Sports Nutrition: Body-recomposition powders, thermogenesis-supporting beverages.
Metabolic Formulas: Insulin-sensitivity blends, T2DM adjunct nutraceuticals.
Sports Nutrition: Body-recomposition powders, thermogenesis-supporting beverages.
Functional Foods: High-fiber baked goods (pasteurized form tolerant), dairy alternatives.
Medical Food: NAFLD/Metabolic syndrome support (subject to local regs).
Typical Specifications
| Product Name | Akkermansia muciniphila AKK PROBIO (Metabolic Grade) |
| Key Biomarkers | P9 Protein / Amuc_1100 Outer Membrane Protein Retained |
| Form | Live (≥10¹² AFU/g) / Pasteurized (Stable Postbiotic) |
| Biomass | ≥ 3.0×10¹¹ AFU/g (n-AFU/g) |
| Appearance | Off-white to Beige Fine Powder |
| Purity | Total plate count ≤1,000 CFU/g; Pathogen Negative |
| Compliance | US FDA GRAS; ISO/HACCP/Kosher/Halal |
| Shelf Life | 24 Months |